港股公告掘金 | 百度集团-SW一季度归母净利润77.17亿元同比增加41.65%

智通财经2025-05-21

重大事项：石四药集团(02005)：取得国家药监局有关盐酸决奈达隆片(400mg)及注射用甲磺酸加贝酯(0.1g)的药品生产注册批件诺诚健华(09969)：国家药监局批准MINJUVI® (TAFASITAMAB)与来那度胺联合治疗中国复发或难治性弥漫性大B细胞淋巴瘤成年患者上海医药(02607)：重酒石酸去甲肾上腺素注射液通过仿制药一致性评价瑛泰医疗(01501)拟收购杭州唯强医疗科技控股权以...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2537934279?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-21 22:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2537934279","market":"us","top_or_hot":-1,"title":"港股公告掘金 | 百度集团-SW一季度归母净利润77.17亿元 同比增加41.65%","media":"智通财经","content":"<div>\n<p>重大事项：石四药集团(02005)：取得国家药监局有关盐酸决奈达隆片(400mg)及注射用甲磺酸加贝酯(0.1g)的药品生产注册批件诺诚健华(09969)：国家药监局批准MINJUVI® (TAFASITAMAB)与来那度胺联合治疗中国复发或难治性弥漫性大B细胞淋巴瘤成年患者上海医药(02607)：重酒石酸去甲肾上腺素注射液通过仿制药一致性评价瑛泰医疗(01501)拟收购杭州唯强医疗科技控股权以...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1296082.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股公告掘金 | 百度集团-SW一季度归母净利润77.17亿元 同比增加41.65%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股公告掘金 | 百度集团-SW一季度归母净利润77.17亿元 同比增加41.65%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-21 22:43 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1296082.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>重大事项：石四药集团(02005)：取得国家药监局有关盐酸决奈达隆片(400mg)及注射用甲磺酸加贝酯(0.1g)的药品生产注册批件诺诚健华(09969)：国家药监局批准MINJUVI® (TAFASITAMAB)与来那度胺联合治疗中国复发或难治性弥漫性大B细胞淋巴瘤成年患者上海医药(02607)：重酒石酸去甲肾上腺素注射液通过仿制药一致性评价瑛泰医疗(01501)拟收购杭州唯强医疗科技控股权以...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1296082.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"YANG","symbol_name":"三倍做空富时中国ETF-Direxion","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1296082.html","article_id":"2537934279","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2537934279","pubTimestamp":1747838604,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"重大事项：石四药集团(02005)：取得国家药监局有关盐酸决奈达隆片(400mg)及注射用甲磺酸加贝酯(0.1g)的药品生产注册批件诺诚健华(09969)：国家药监局批准MINJUVI (TAFASITAMAB)与来那度胺联合治疗中国复发或难治性弥漫性大B细胞淋巴瘤成年患者上海医药(02607)：重酒石酸去甲肾上腺素注射液通过仿制药一致性评价瑛泰医疗(01501)拟收购杭州唯强医疗科技控股权以进一","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"YANG":"三倍做空富时中国ETF-Direxion","HSTECH":"恒生科技指数","09969":"诺诚健华","BIDU":"百度","HSCEI":"国企指数","SW":"Smurfit WestRock PLC","09888":"百度集团-SW","02607":"上海医药","02005":"石四药集团","01501":"瑛泰医疗","00690":"联康生物科技集团"},"translate_title":"Hong Kong stock announcement Nuggets Baidu Group-SW's net profit attributable to the parent company in the first quarter was 7.717 billion yuan, a year-on-year increase of 41.65%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"YANG":1,"09969":0.9,"09888":1,"02607":0.9,"HSTECH":1,"SW":1,"00690":0.9,"01501":0.9,"BIDU":1,"HSCEI":1,"02005":0.9},"content_text":"重大事项：石四药集团(02005)：取得国家药监局有关盐酸决奈达隆片(400mg)及注射用甲磺酸加贝酯(0.1g)的药品生产注册批件诺诚健华(09969)：国家药监局批准MINJUVI® (TAFASITAMAB)与来那度胺联合治疗中国复发或难治性弥漫性大B细胞淋巴瘤成年患者上海医药(02607)：重酒石酸去甲肾上腺素注射液通过仿制药一致性评价瑛泰医疗(01501)拟收购杭州唯强医疗科技控股权以进一步完善公司在主动脉及外周血管介入及植入领域的产品布局联康生物科技集团(00690)：眼科药物金因康®获批上市MAYER HOLDINGS(01116)对PCM业务前景持乐观态度，并将继续探索及把握新的合作机会经营业绩：滔搏(06110)发布年度业绩 权益持有人应占溢利12.86亿元 同比减少41.89%宝尊电商-W(09991)发布一季度业绩 普通股股东应占净损失6308万元 同比收窄5.34%特海国际(09658)发布一季度业绩 股东应占溢利1193.8万美元 同比扭亏为盈小鹏汽车-W(09868)发布一季度业绩，股东应占净亏损6.6亿元 同比下降51.5% 单季交付再创历史新高百度集团-SW(09888)一季度归母净利润77.17亿元 同比增加41.65%微博-SW(09898)一季度股东应占净利润为1.07亿美元 同比增长116.36%中通快递-W(02057)一季度净利润同比增长40.9%至20.392亿元，包裹量同比增长19.1%","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2537934279","isCrawlerRequest":true}

港股公告掘金 | 百度集团-SW一季度归母净利润77.17亿元 同比增加41.65%

精彩评论

港股公告掘金 | 百度集团-SW一季度归母净利润77.17亿元同比增加41.65%